Trials / Completed
CompletedNCT00942435
A Study to Assess the Effect of YM150 for Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery
A Randomized, Open Label Parallel Group Mechanical Prophylaxis Controlled Comparison Study With YM150, a Direct Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 156 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate the efficacy and safety of the oral dose of YM150 for prevention of venous thromboembolism (VTE) in patients undergoing major abdominal surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | YM150 | oral |
| PROCEDURE | mechanical prophylaxis | The investigator will determine the method of mechanical prophylaxis |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2010-04-01
- Completion
- 2010-04-01
- First posted
- 2009-07-20
- Last updated
- 2010-06-16
Locations
6 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00942435. Inclusion in this directory is not an endorsement.